Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-005738
Filing Date
2021-02-10
Accepted
2021-02-10 18:53:31
Documents
1
Period of Report
2021-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10889
  Complete submission text file 0000899243-21-005738.txt   12243
Mailing Address 307 WESTLAKE AVE. NORTH, STE. 300 SEATTLE WA 98109
Business Address
Harr Steve (Reporting) CIK: 0001627387 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 21615715

Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)